Form 4 for RCEL AVITA Medical, Inc.
Accepted 2022-07-06 00:00:00 ET · period of report 2022-07-01 · accession 0001209191-22-041375 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-06 | 2022-07-01 | RCEL | Quick Andrew | CTO | A - Grant | — | +36.0K | 46.5K | +342% | — |
| D | 2022-07-06 | 2022-07-01 | RCEL | Quick Andrew | CTO | A - Grant | $0.00 | +20.6K | 20.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | A | A | 35,950 | — | 46,450 | D | — | — | (F1) Reflects Restricted Stock Units, each representing a contingent right to be issued one share of Common Stock. These Restricted Stock Units vest in four equal annual installments beginning on August 20, 2023. (F2) Includes unvested Restricted Stock Units. |
| 2 | Derivative | Stock Options (Right to Buy) | 2022-07-01 | A | A | 20,650 | $0.00 | 20,650 | D | $4.97 · — to 2032-07-01 | 20,650 Common Stock | (F3) These Stock Options vest in four equal annual installments beginning on August 20, 2023. |